Published in Am J Pathol on July 16, 2009
Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesis. Cell Res (2011) 1.24
The SLIT-ROBO pathway: a regulator of cell function with implications for the reproductive system. Reproduction (2010) 1.14
Differential expression of microRNAs between eutopic and ectopic endometrium in ovarian endometriosis. J Biomed Biotechnol (2010) 1.06
A conditionally replicative adenovirus, CRAd-S-pK7, can target endometriosis with a cell-killing effect. Hum Reprod (2010) 0.84
Over-expression of Slit2 induces vessel formation and changes blood vessel permeability in mouse brain. Acta Pharmacol Sin (2011) 0.83
Expression of the repulsive SLIT/ROBO pathway in the human endometrium and Fallopian tube. Mol Hum Reprod (2010) 0.82
Peripheral changes in endometriosis-associated pain. Hum Reprod Update (2014) 0.82
Slit2 overexpression results in increased microvessel density and lesion size in mice with induced endometriosis. Reprod Sci (2012) 0.81
Possible Loss of GABAergic Inhibition in Mice With Induced Adenomyosis and Treatment With Epigallocatechin-3-Gallate Attenuates the Loss With Improved Hyperalgesia. Reprod Sci (2014) 0.76
Macrophage and nerve interaction in endometriosis. J Neuroinflammation (2017) 0.75
Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. J Natl Cancer Inst (2008) 6.79
Slit proteins bind Robo receptors and have an evolutionarily conserved role in repulsive axon guidance. Cell (1999) 5.42
Bias as a threat to the validity of cancer molecular-marker research. Nat Rev Cancer (2005) 4.43
Directional guidance of neuronal migration in the olfactory system by the protein Slit. Nature (1999) 3.51
The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factors. Nature (2001) 3.45
Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity. Cancer Cell (2003) 3.14
Biochemical purification of a mammalian slit protein as a positive regulator of sensory axon elongation and branching. Cell (1999) 2.80
Blood vessels and nerves: common signals, pathways and diseases. Nat Rev Genet (2003) 2.51
Magic roundabout is a new member of the roundabout receptor family that is endothelial specific and expressed at sites of active angiogenesis. Genomics (2002) 2.21
roundabout4 is essential for angiogenesis in vivo. Proc Natl Acad Sci U S A (2005) 1.69
Damage to ovarian reserve associated with laparoscopic excision of endometriomas: a quantitative rather than a qualitative injury. Am J Obstet Gynecol (2005) 1.56
Structural insights into the Slit-Robo complex. Proc Natl Acad Sci U S A (2007) 1.54
Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod (1998) 1.48
Angiogenic factors in endometriosis. Ann N Y Acad Sci (2002) 1.44
Extracts from the "clinical evidence". Endometriosis. BMJ (2000) 1.37
Antiangiogenic agents are effective inhibitors of endometriosis. J Clin Endocrinol Metab (2003) 1.34
Antiangiogenesis therapy for endometriosis. J Clin Endocrinol Metab (2004) 1.28
Mechanistic and therapeutic implications of angiogenesis in endometriosis. Reprod Sci (2008) 1.24
Does laparoscopic excision of endometriotic ovarian cysts significantly affect ovarian reserve? Insights from IVF cycles. Hum Reprod (2003) 1.21
Recent advances in endometrial angiogenesis research. Angiogenesis (2005) 1.20
Targeting Slit-Roundabout signaling inhibits tumor angiogenesis in chemical-induced squamous cell carcinogenesis. Cancer Sci (2008) 1.18
Vascular development in endometriosis. Angiogenesis (2005) 1.15
Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod (1996) 1.12
Histopathological analysis of laparoscopically treated ovarian endometriotic cysts with special reference to loss of follicles. Hum Reprod (2002) 1.08
Angiogenesis and antiangiogenic therapy in endometriosis. Microvasc Res (2007) 1.02
The effectiveness of laparoscopic excision of endometriosis. Curr Opin Obstet Gynecol (2004) 1.02
Lymph node involvement and lymphovascular invasion in deep infiltrating rectosigmoid endometriosis. Fertil Steril (2007) 0.96
Surgical treatment of deep endometriosis and risk of recurrence. J Minim Invasive Gynecol (2005) 0.96
Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo. Hum Reprod (2008) 0.95
Endometriosis of the bowel with lymph node involvement. A report of three cases and review of the literature. Pathol Res Pract (1996) 0.94
Patterns of and risk factors for recurrence in women with ovarian endometriomas. Obstet Gynecol (2007) 0.93
Ovarian recovery after laparoscopic enucleation of ovarian cysts: insights from echographic short-term postsurgical follow-up. J Minim Invasive Gynecol (2005) 0.91
Staging of pelvic endometriosis: role of sonographic appearance in determining extension of disease and modulating surgical approach. J Am Assoc Gynecol Laparosc (2003) 0.91
Influence of menstrual cycle on circulating endothelial progenitor cells. Hum Reprod (2008) 0.90
[Rectosigmoid endometriosis with lymph node involvement]. Gastroenterol Hepatol (2003) 0.89
Mass screening for endometrial cancer directed in risk groups of patients with diabetes and patients with hypertension. Cancer (1993) 0.87
A 42-year-old woman with a 7-month history of abdominal pain. A, endometriosis involving ileocecal junction and 2 pericolonic lymph nodes; B, intranodal benign glandular inclusions. Arch Pathol Lab Med (2005) 0.86
Recurrence of endometriomas after laparoscopic removal: sonographic and clinical follow-up and indication for second surgery. J Minim Invasive Gynecol (2006) 0.83
A rare case of rectovaginal endometriosis with lymph node involvement. Gynecol Obstet Invest (2006) 0.82
Endometriosis: absence of recurrence in patients after endometrial ablation. Hum Reprod (2001) 0.81
Immunoreactivity of progesterone receptor isoform B and nuclear factor kappa-B as biomarkers for recurrence of ovarian endometriomas. Am J Obstet Gynecol (2008) 0.79
Expression of angiogenic factors in extrapelvic endometriosis. Oncol Rep (2001) 0.79
Does laparoscopic removal of nonendometriotic benign ovarian cysts affect ovarian reserve? Acta Obstet Gynecol Scand (2006) 0.79
Histologic study of ovarian endometriosis after hormonal therapy. Fertil Steril (1988) 0.78
Cyclooxygenase-2 overexpression in ovarian endometriomas is associated with higher risk of recurrence. Fertil Steril (2008) 0.78
Induction of intestinal stem cells by R-spondin 1 and Slit2 augments chemoradioprotection. Nature (2013) 1.91
P-selectin primes leukocyte integrin activation during inflammation. Nat Immunol (2007) 1.64
Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. J Immunol (2004) 1.58
Src activates Abl to augment Robo1 expression in order to promote tumor cell migration. Oncotarget (2010) 1.52
A pilot study on the off-label use of valproic acid to treat adenomyosis. Fertil Steril (2007) 1.45
Slit2 involvement in glioma cell migration is mediated by Robo1 receptor. J Neurooncol (2007) 1.41
P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis. Arch Immunol Ther Exp (Warsz) (2006) 1.38
Repulsive axon guidance molecule Slit3 is a novel angiogenic factor. Blood (2009) 1.37
Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics (2006) 1.36
Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis. Am J Obstet Gynecol (2005) 1.26
Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesis. Cell Res (2011) 1.24
HDAC5 is a repressor of angiogenesis and determines the angiogenic gene expression pattern of endothelial cells. Blood (2009) 1.23
Three color cDNA microarrays: quantitative assessment through the use of fluorescein-labeled probes. Nucleic Acids Res (2003) 1.18
Targeting Slit-Roundabout signaling inhibits tumor angiogenesis in chemical-induced squamous cell carcinogenesis. Cancer Sci (2008) 1.18
Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis. Fertil Steril (2006) 1.12
Transcriptional characterizations of differences between eutopic and ectopic endometrium. Endocrinology (2005) 1.11
Slit-Robo signaling mediates lymphangiogenesis and promotes tumor lymphatic metastasis. Biochem Biophys Res Commun (2010) 1.06
Down-regulation of the progesterone receptor by the methylation of progesterone receptor gene in endometrial cancer cells. Cancer Genet Cytogenet (2007) 1.00
Slit2 regulates attractive eosinophil and repulsive neutrophil chemotaxis through differential srGAP1 expression during lung inflammation. J Immunol (2010) 0.99
Effect of nerve-sparing radical hysterectomy on bladder function recovery and quality of life in patients with cervical carcinoma. Int J Gynecol Cancer (2010) 0.98
IFN regulatory factor-1 is required for the up-regulation of the CD40-NF-kappa B activator 1 axis during airway inflammation. J Immunol (2003) 0.97
NF-kappaB transcription factor p50 critically regulates tissue factor in deep vein thrombosis. J Biol Chem (2008) 0.95
Sibling recurrence risk ratio as a measure of genetic effect: caveat emptor! Am J Hum Genet (2002) 0.95
Plant lectin can target receptors containing sialic acid, exemplified by podoplanin, to inhibit transformed cell growth and migration. PLoS One (2012) 0.95
Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice. Hum Reprod (2010) 0.95
Mst1/Mst2 regulate development and function of regulatory T cells through modulation of Foxo1/Foxo3 stability in autoimmune disease. J Immunol (2014) 0.94
Patterns of and risk factors for recurrence in women with ovarian endometriomas. Obstet Gynecol (2007) 0.93
Conditions to ensure competitive hybridization in two-color microarray: a theoretical and experimental analysis. Biotechniques (2002) 0.93
Constitutive and tumor necrosis factor-α-induced activation of nuclear factor-κB in adenomyosis and its inhibition by andrographolide. Fertil Steril (2013) 0.92
SAP suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice. Immunol Cell Biol (2011) 0.92
Resolution of clonal origins for endometriotic lesions using laser capture microdissection and the human androgen receptor (HUMARA) assay. Fertil Steril (2003) 0.92
Statistical methods for detecting genomic alterations through array-based comparative genomic hybridization (CGH). Front Biosci (2004) 0.92
Immunoreactivity of oxytocin receptor and transient receptor potential vanilloid type 1 and its correlation with dysmenorrhea in adenomyosis. Am J Obstet Gynecol (2010) 0.91
Andrographolide inhibits NF-kappaBeta activation and attenuates neointimal hyperplasia in arterial restenosis. Cell Res (2007) 0.91
Trichostatin A, a histone deacetylase inhibitor, attenuates invasiveness and reactivates E-cadherin expression in immortalized endometriotic cells. Reprod Sci (2007) 0.90
Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer. Carcinogenesis (2013) 0.90
Dysmenorrhea and its severity are associated with increased uterine contractility and overexpression of oxytocin receptor (OTR) in women with symptomatic adenomyosis. Fertil Steril (2012) 0.89
P-selectin cross-links PSGL-1 and enhances neutrophil adhesion to fibrinogen and ICAM-1 in a Src kinase-dependent, but GPCR-independent mechanism. Cell Adh Migr (2007) 0.89
Identification of alternatively spliced Act1 and implications for its roles in oncogenesis. Biochem Biophys Res Commun (2002) 0.88
Perspectives of SLIT/ROBO signaling in placental angiogenesis. Histol Histopathol (2010) 0.87
The link between endometriosis and ovarian cancer: clinical implications. Int J Gynecol Cancer (2014) 0.87
The search for genetic variants predisposing women to endometriosis. Curr Opin Obstet Gynecol (2007) 0.87
Histone deacetylase inhibitors trichostatin A and valproic acid induce cell cycle arrest and p21 expression in immortalized human endometrial stromal cells. Eur J Obstet Gynecol Reprod Biol (2007) 0.87
Increased SLIT immunoreactivity as a biomarker for recurrence in endometrial carcinoma. Am J Obstet Gynecol (2009) 0.87
Immunoreactivity of progesterone receptor isoform B, nuclear factor kappaB, and IkappaBalpha in adenomyosis. Fertil Steril (2009) 0.86
Valproic acid and progestin inhibit lesion growth and reduce hyperalgesia in experimentally induced endometriosis in rats. Reprod Sci (2012) 0.86
Loss of redox factor 1 decreases NF-kappaB activity and increases susceptibility of endothelial cells to apoptosis. Arterioscler Thromb Vasc Biol (2004) 0.85
Clinical profiles of 710 premenopausal women with adenomyosis who underwent hysterectomy. J Obstet Gynaecol Res (2013) 0.85
Generalized hyperalgesia in women with endometriosis and its resolution following a successful surgery. Reprod Sci (2010) 0.84
The expression and functionality of transient receptor potential vanilloid 1 in ovarian endometriomas. Reprod Sci (2012) 0.84
[Four surgical patterns of hysterectomy for uterine without prolapsis: a clinical study]. Zhonghua Yi Xue Za Zhi (2002) 0.84
Acadesine inhibits tissue factor induction and thrombus formation by activating the phosphoinositide 3-kinase/Akt signaling pathway. Arterioscler Thromb Vasc Biol (2010) 0.84
Promoter hypermethylation of progesterone receptor isoform B (PR-B) in adenomyosis and its rectification by a histone deacetylase inhibitor and a demethylation agent. Reprod Sci (2010) 0.84
Genomic alterations in ectopic and eutopic endometria of women with endometriosis. Gynecol Obstet Invest (2006) 0.84
Conserved molecular players for axon guidance and angiogenesis. Curr Protein Pept Sci (2005) 0.84
Effect of N-desulfated heparin on hepatic/renal ischemia reperfusion injury in rats. World J Gastroenterol (2002) 0.84
Affinity and kinetics of P-selectin binding to heparin. Thromb Haemost (2003) 0.84
Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages. J Pharmacol Exp Ther (2005) 0.83
Peroxisome proliferator-activated receptor-gamma and retinoid X receptor agonists synergistically suppress proliferation of immortalized endometrial stromal cells. Fertil Steril (2008) 0.83
The knockdown of progesterone receptor isoform B (PR-B) promotes proliferation in immortalized endometrial stromal cells. Fertil Steril (2008) 0.83
Obligatory requirement of sulfation for P-selectin binding to human salivary gland carcinoma Acc-M cells and breast carcinoma ZR-75-30 cells. J Immunol (2002) 0.82
Valproic acid alleviates generalized hyperalgesia in mice with induced adenomyosis. J Obstet Gynaecol Res (2011) 0.82
Therapeutic potential of andrographolide for treating endometriosis. Hum Reprod (2012) 0.82
Slit-2 repels the migration of olfactory ensheathing cells by triggering Ca2+-dependent cofilin activation and RhoA inhibition. J Cell Sci (2011) 0.82
Epigallocatechin-3-gallate reduces myometrial infiltration, uterine hyperactivity, and stress levels and alleviates generalized hyperalgesia in mice induced with adenomyosis. Reprod Sci (2013) 0.81
Slit2 overexpression results in increased microvessel density and lesion size in mice with induced endometriosis. Reprod Sci (2012) 0.81
A system-wide analysis of differentially expressed genes in ectopic and eutopic endometrium. Hum Reprod (2007) 0.81
Sexuality after laparoscopic peritoneal vaginoplasty in women with Mayer-Rokitansky-Kuster-Hauser syndrome. J Minim Invasive Gynecol (2009) 0.81
Prolonged stimulation with tumor necrosis factor-alpha induced partial methylation at PR-B promoter in immortalized epithelial-like endometriotic cells. Fertil Steril (2007) 0.80
A 28-kDa glycoprotein functions as a platelet ligand for P-selectin (CD62P). Thromb Haemost (2002) 0.80
Elevated immunoreactivity against class I histone deacetylases in adenomyosis. Gynecol Obstet Invest (2012) 0.80
Effect of non-anticoagulant N-desulfated heparin on expression of vascular endothelial growth factor, angiogenesis and metastasis of orthotopic implantation of human gastric carcinoma. World J Gastroenterol (2007) 0.79
Aberrant immunoreactivity of deoxyribonucleic acid methyltransferases in adenomyosis. Gynecol Obstet Invest (2012) 0.79
Capsaicin inhibits proliferation of endometriotic cells in vitro. Gynecol Obstet Invest (2008) 0.79
Constructing predictive models for vaginal surgery in patients with noninvasive gynecological conditions. Acta Obstet Gynecol Scand (2014) 0.79
Suppression of IL-1beta-induced COX-2 expression by trichostatin A (TSA) in human endometrial stromal cells. Eur J Obstet Gynecol Reprod Biol (2007) 0.79
Immunoreactivity of progesterone receptor isoform B and nuclear factor kappa-B as biomarkers for recurrence of ovarian endometriomas. Am J Obstet Gynecol (2008) 0.79
Constitutive and tumor necrosis factor-alpha-stimulated activation of nuclear factor-kappaB in immortalized endometriotic cells and their suppression by trichostatin A. Gynecol Obstet Invest (2010) 0.78
Cyclooxygenase-2 overexpression in ovarian endometriomas is associated with higher risk of recurrence. Fertil Steril (2008) 0.78
SH3KBP1-binding protein 1 prevents epidermal growth factor receptor degradation by the interruption of c-Cbl-CIN85 complex. Cell Biochem Funct (2011) 0.78
Adenosine receptor A2A deficiency in leukocytes increases arterial neointima formation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2010) 0.78